Sarepta Therapeutics (SRPT) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.99% |
| Dec 31, 2025 | 15.14% |
| Sep 30, 2025 | 18.77% |
| Jun 30, 2025 | 17.24% |
| Mar 31, 2025 | 24.78% |
| Dec 31, 2024 | -3.79% |
| Sep 30, 2024 | -2.70% |
| Jun 30, 2024 | -5.77% |
| Mar 31, 2024 | -0.68% |
| Dec 31, 2023 | -7.38% |
| Sep 30, 2023 | -16.94% |
| Jun 30, 2023 | -14.41% |
| Mar 31, 2023 | -12.40% |
| Dec 31, 2022 | -13.01% |
| Sep 30, 2022 | -27.40% |
| Jun 30, 2022 | -44.99% |
| Mar 31, 2022 | -38.84% |
| Dec 31, 2021 | -46.10% |
| Sep 30, 2021 | -31.16% |
| Jun 30, 2021 | -96.32% |
| Mar 31, 2021 | -62.47% |
| Dec 31, 2020 | -84.37% |
| Sep 30, 2020 | -78.61% |
| Jun 30, 2020 | -87.44% |
| Mar 31, 2020 | -86.94% |
| Dec 31, 2019 | -39.84% |
| Sep 30, 2019 | -79.49% |
| Jun 30, 2019 | -59.53% |
| Mar 31, 2019 | -42.95% |
| Dec 31, 2018 | -34.75% |
| Sep 30, 2018 | -23.06% |
| Jun 30, 2018 | -42.17% |
| Mar 31, 2018 | -44.26% |
| Dec 31, 2017 | -41.88% |
| Sep 30, 2017 | -74.67% |
| Jun 30, 2017 | -65.16% |
| Mar 31, 2017 | -66.42% |
| Dec 31, 2016 | -51.44% |
| Sep 30, 2016 | -54.79% |
| Jun 30, 2016 | -1.80% |
| Mar 31, 2016 | -45.83% |
| Dec 31, 2015 | -22.06% |
| Sep 30, 2015 | -22.67% |
| Jun 30, 2015 | -19.38% |